Search

Your search keyword '"Sharpe, Hannah R."' showing total 19 results

Search Constraints

Start Over You searched for: Author "Sharpe, Hannah R." Remove constraint Author: "Sharpe, Hannah R."
19 results on '"Sharpe, Hannah R."'

Search Results

2. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

3. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

4. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

5. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

7. Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E

8. CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination

9. IMMUNOLOGY: Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E

10. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

11. The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world

12. Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients

13. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

14. Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce robust immune responses in mice

15. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

16. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

18. Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients.

19. Broadly targeted CD8+T cell responses restricted by major histocompatibility complex E

Catalog

Books, media, physical & digital resources